Early 18F-FDG uptake as a reliable imaging biomarker of T790M-mediated resistance but not MET amplification in NSCLC

被引：0
|
作者：
De Rosa, V. [1 ]
Iommelli, F. [1 ]
Monti, M. [2 ]
Mainolfi, C. [2 ]
Fonti, R. [1 ]
Del Vecchio, S. [2 ]
机构：
[1] CNR, Inst Biostruct & Bioimages, Naples, Italy
[2] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2015年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP303
引用
收藏
页码：S127 / S127
页数：1
相关论文
共 25 条
  • [21] Evaluation of 18F-FDG PET/CT as an early imaging biomarker for response monitoring after radiochemotherapy using cetuximab in head and heck squamous cell carcinoma
    Barbosa, Felipe de Galiza
    Riesterer, Oliver
    Tanadini-Lang, Stephanie
    Stieb, Sonja
    Studer, Gabriela
    Pruschy, Martin
    Huber, Gerhard F.
    Huellner, Martin W.
    Stolzmann, Paul
    Veit-Haibach, Patrick
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2020, 42 (02): : 163 - 170
  • [22] Noninvasive, Highly Specific Detection of T790M-Mediated Acquired Resistance in EGFR Mutant NSCLC Using a Novel Droplet Digital PCR (ddPCR)-Based Cell-free Plasma DNA (cfDNA) Assay
    Sacher, A. G.
    Mach, S.
    Messineo, M.
    Jackman, D. M.
    Jaenne, P. A.
    Paweletz, C. P.
    Oxnard, G. R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S71 - S71
  • [23] CD147-mediated glucose metabolic regulation contributes to the predictive role of 18F-FDG PET/CT imaging for EGFR-TKI treatment sensitivity in NSCLC
    Li, Xiaofeng
    Fu, Qiang
    Zhu, Yanjia
    Wang, Jian
    Liu, Jianjing
    Yu, Xiaozhou
    Xu, Wengui
    MOLECULAR CARCINOGENESIS, 2019, 58 (02) : 247 - 257
  • [24] Early Imaging Biomarker of Myocardial Glucose Adaptations in High-Fat-Diet-Induced Insulin Resistance Model by Using 18F-FDG PET and [U-13C]glucose Nuclear Magnetic Resonance Tracer
    Chung, Yi-Hsiu
    Lu, Kuan-Ying
    Chiu, Shao-Chieh
    Lo, Chi-Jen
    Hung, Li-Man
    Huang, Jiung-Pang
    Cheng, Mei-Ling
    Wang, Chao-Hung
    Tsai, Cheng-Kun
    Lin, Yu-Chun
    Chang, Shang-Hung
    Lin, Gigin
    CONTRAST MEDIA & MOLECULAR IMAGING, 2018,
  • [25] Combination of c-Met inhibitor tepotinib (MSC2156119J) and a third-generation EGFR inhibitor can overcome double resistance mediated by EGFR T790M mutation and c-Met amplification in non-small cell lung cancer models
    Friese-Hamim, Manja
    Locatelli, Giuseppe
    Bladt, Friedhelm
    CANCER RESEARCH, 2016, 76
123